Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure

Life Sciences

Volumn 85, Issue 5-6, 2009, Pages 248-254

  Polissidis, Alexia ^a,b   Chouliara, Olga ^a   Galanopoulos, Andreas ^b   Marselos, Marios ^a   Papadopoulou Daifoti, Zeta ^b   Antoniou, Katerina ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cannabinoid; Cocaine; Conditioned place preference; d amphetamine; Dopamine; Motor activity; Rat; Reward; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; COCAINE; DEXAMPHETAMINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; DRUG DOSE COMPARISON; HABITUATION; HIPPOCAMPUS; HYPERACTIVITY; LOW DRUG DOSE; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTOR ACTIVITY; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD TEST; PLACE PREFERENCE; PREFRONTAL CORTEX; RAT;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZOXAZINES; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; ORIENTATION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 67649781656     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.05.015     Document Type: Article

References (71)

1. Adams I.B., and Martin B.R. Cannabis: Pharmacology and toxicology in animals and humans. Addiction 91 11 (1996) 1585-1614
2. Antoniou K., Kafetzopoulos E., Papadopoulou-Daifoti Z., Hyphantis T., and Marselos M. d-amphetamine, cocaine and caffeine: A comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neuroscience and Biobehavioral Reviews 23 2 (1998) 189-196
3. Antoniou K., Papadopoulou-Daifotis Z., and Kafetzopoulos E. Differential alterations in basal and d-amphetamine-induced behavioural pattern following 6-OHDA or ibotenic acid lesions into the dorsal striatum. Behavioural Brain Research 97 1-2 (1998) 13-28
4. Arnold J.C., Topple A.N., Hunt G.E., and McGregor I.S. Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. European Journal of Pharmacology 354 1 (1998) 9-16
5. Bardo M.T. Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens. Critical Reviews in Neurobiology 12 1-2 (1998) 37-67
6. Bortolato M., Campolongo P., Mangieri R.A., Scattoni M.L., Frau R., Trezza V., La Rana G., Russo R., Calignano A., Gessa G.L., Cuomo V., and Piomelli D. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31 12 (2006) 2652-2659
7. Braida D., Iosue S., Pegorini S., and Sala M. Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats. European Journal of Pharmacology 506 1 (2004) 63-69
8. Braida D., Pozzi M., Cavallini R., and Sala M. Conditioned place preference induced by the cannabinoid agonist CP 55,940: Interaction with the opioid system. Neuroscience 104 4 (2001) 923-926
9. Brabant C., Quertemont E., and Tirelli E. Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL/6J mice. Psychopharmacology (Berl) 180 1 (2005) 33-40
10. Campbell J.O., Wood R.D., and Spear L.P. Cocaine and morphine-induced place conditioning in adolescent and adult rats. Physiology and Behavior 68 4 (2000) 487-493
11. Chaperon F., Soubrie P., Puech A.J., and Thiebot M.H. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl) 135 4 (1998) 324-332
12. Cheer J.F., Aragona B.J., Heien M.L., Seipel A.T., Carelli R.M., and Wightman R.M. Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 54 2 (2007) 237-244
13. Chen K., Kandel D.B., and Davies M. Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug and Alcohol Dependence 46 1-2 (1997) 53-67
14. Commissiong J.W. Monoamine metabolites: Their relationship and lack of relationship to monoaminergic neuronal activity. Biochemical Pharmacology 34 8 (1985) 1127-1131
15. Davis W.M., Moreton J.E., King W.T., and Pace H.B. Marihuana on locomotor activity: Biphasic effect and tolerance development. Research Communications in Chemical Pathology and Pharmacology 3 1 (1972) 29-35
16. de Wit H., and Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) 75 2 (1981) 134-143
17. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences 85 14 (1988) 5274-5278
18. Drews E., Schneider M., and Koch M. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats. Pharmacology, Biochemistry and Behavior 80 1 (2005) 145-150
19. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., and Robbins T.W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Annals of the New York Academy of Sciences 877 (1999) 412-438
20. Fadda P., Scherma M., Spano M.S., Salis P., Melis V., Fattore L., and Fratta W. Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport 17 15 (2006) 1629-1632
21. Feenstra M.G., Botterblom M.H., and van Uum J.F. Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: Inhibition by diazepam. Neuroscience Letters 189 2 (1995) 81-84
22. Feingold A., and Rounsaville B. Construct validity of the dependence syndrome as measured by DSM-IV for different psychoactive substances. Addiction 90 12 (1995) 1661-1669
23. Fontana D.J., Post R.M., and Pert A. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Research 629 1 (1993) 31-39
24. Gardner E.L. Addictive potential of cannabinoids: The underlying neurobiology. Chemistry and Physics of Lipids 121 1-2 (2002) 267-290
25. Gardner E.L. Endocannabinoid signaling system and brain reward: Emphasis on dopamine. Pharmacology, Biochemistry and Behavior 81 2 (2005) 263-284
26. Gorriti M.A., Ferrer B., del Arco I., Bermudez-Silva F.J., de Diego Y., Fernandez-Espejo E., Navarro M., and Rodriguez de Fonseca F. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion. Pharmacology Biochemistry and Behavior 81 1 (2005) 71-77
27. Gorriti M.A., Rodriguez de Fonseca F., Navarro M., and Palomo T. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. European Journal of Pharmacology 365 2-3 (1999) 133-142
28. Gratton A., and Wise R.A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. Journal of Neuroscience 14 7 (1994) 4130-4146
29. Ito R., Dalley J.W., Howes S.R., Robbins T.W., and Everitt B.J. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. Journal of Neuroscience 20 19 (2000) 7489-7495
30. Kilpatrick I.C., Jones M.W., and Phillipson O.T. A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: An isocratic HPLC technique employing coulometric detection and minimal sample preparation. Journal of Neurochemistry 46 6 (1986) 1865-1876
31. Kiyatkin E.A., and Stein E.A. Conditioned changes in nucleus accumbens dopamine signal established by intravenous cocaine in rats. Neuroscience Letters 211 2 (1996) 73-76
32. Krasnova I.N., Li S.M., Wood W.H., McCoy M.T., Prabhu V.V., Becker K.G., Katz J.L., and Cadet J.L. Transcriptional responses to reinforcing effects of cocaine in the rat hippocampus and cortex. Genes, Brain and Behavior 7 2 (2008) 193-202
33. Lamarque S., Taghzouti K., and Simon H. Chronic treatment with delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Neuropharmacology 41 1 (2001) 118-129
34. Le Foll B., Wiggins M., and Goldberg S.R. Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of delta-9-tetrahydrocannabinol in rats. Behavioural Pharmacology 17 2 (2006) 195-199
35. Legault M., and Wise R.A. Novelty-evoked elevations of nucleus accumbens dopamine: Dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. European Journal of Neuroscience 13 4 (2001) 819-828
36. Lepore M., Vorel S.R., Lowinson J., and Gardner E.L. Conditioned place preference induced by delta 9-tetrahydrocannabinol: Comparison with cocaine, morphine, and food reward. Life Sciences 56 23-24 (1995) 2073-2080
37. Lin S.K., Pan W.H., and Yeh P.H. Prefrontal dopamine efflux during exposure to drug-associated contextual cues in rats with prior repeated methamphetamine. Brain Research Bulletin 71 4 (2007) 365-371
38. Mallet P.E., and Beninger R.J. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sciences 62 26 (1998) 2431-2439
39. Manzanedo C., Aguilar M.A., Rodriguez-Arias M., Navarro M., and Minarro J. Cannabinoid agonist-induced sensitisation to morphine place preference in mice. Neuroreport 15 8 (2004) 1373-1377
40. Martin M., Ledent C., Parmentier M., Maldonado R., and Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. European Journal of Neuroscience 12 11 (2000) 4038-4046
41. McGregor I.S., Issakidis C.N., and Prior G. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacology, Biochemistry and Behavior 53 3 (1996) 657-664
42. Meyers R.A., Zavala A.R., Speer C.M., and Neisewander J.L. Dorsal hippocampus inhibition disrupts acquisition and expression, but not consolidation, of cocaine conditioned place preference. Behavioral Neuroscience 120 2 (2006) 401-412
43. Moreno M., Lopez-Moreno J.A., Rodriguez de Fonseca F., and Navarro M. Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats. Behavioural Pharmacology 16 5-6 (2005) 441-446
44. Morgenstern J., Langenbucher J., and Labouvie E.W. The generalizability of the dependence syndrome across substances: An examination of some properties of the proposed DSM-IV dependence criteria. Addiction 89 9 (1994) 1105-1113
45. Muschamp J.W., and Siviy S.M. Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats. Pharmacology, Biochemistry and Behavior 73 4 (2002) 835-842
46. Panlilio L.V., Solinas M., Matthews S.A., and Goldberg S.R. Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats. Neuropsychopharmacology 32 3 (2007) 646-657
47. Papadopoulou-Daifotis Z., Antoniou K., Vamvakidis A., Kalliteraki I., and Varonos D. Neurochemical changes in dopamine and serotonin turnover rate in discrete regions of rat brain after the administration of glycinergic compounds. Acta Therapeutica 21 (1995) 5-18
48. Parker L.A., and Gillies T. THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behavioral Neuroscience 109 1 (1995) 71-78
49. Petitet F., Jeantaud B., Bertrand P., and Imperato A. Cannabinoid penetration into mouse brain as determined by ex vivo binding. European Journal of Pharmacology 374 3 (1999) 417-421
50. Phillips P.E., Stuber G.D., Heien M.L., Wightman R.M., and Carelli R.M. Subsecond dopamine release promotes cocaine seeking. Nature 422 6932 (2003) 614-618
51. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Journal of Psychopharmacology 17 4 (2003) 415-423
52. Robinson T.E., and Berridge K.C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews 18 3 (1993) 247-291
53. Rouse B.A. Epidemiology of illicit and abused drugs in the general population, emergency department drug-related episodes, and arrestees. Clinical Chemistry 42 8 (1996) 1330-1336
54. Sanudo-Pena M.C., Romero J., Seale G.E., Fernandez-Ruiz J.J., and Walker J.M. Activational role of cannabinoids on movement. European Journal of Pharmacology 391 3 (2000) 269-274
55. Sanudo-Pena M.C., Tsou K., Delay E.R., Hohman A.G., Force M., and Walker J.M. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neuroscience Letters 223 2 (1997) 125-128
56. Sharp T., Zetterstrom T., Series H.G., Carlsson A., Grahame-Smith D.G., and Ungerstedt U. HPLC-EC analysis of catechols and indoles in rat brain dialysates. Life Sciences 41 7 (1987) 869-872
57. Spyraki C., Fibiger H.C., and Phillips A.G. Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine. Brain Research 253 1-2 (1982) 195-203
58. Spyraki C., Fibiger H.C., and Phillips A.G. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Research 253 1-2 (1982) 185-193
59. Sulcova E., Mechoulam R., and Fride E. Biphasic effects of anandamide. Pharmacology, Biochemistry and Behavior 59 2 (1998) 347-352
60. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.L., Fienberg A.A., Nomikos G.G., and Greengard P. Diverse psychotomimetics act through a common signaling pathway. Science 302 5649 (2003) 1412-1415
61. Swift W., Hall W., and Teesson M. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: Results from the National Survey of Mental Health and Wellbeing. Drug and Alcohol Dependence 63 2 (2001) 147-153
62. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 5321 (1997) 2048-2050
63. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade. Addiction Biology 12 3-4 (2007) 227-462
64. Valjent E., and Maldonado R. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 147 4 (2000) 436-438
65. Varvel S.A., Martin B.R., and Lichtman A.H. Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine. Psychopharmacology (Berl) 193 4 (2007) 511-519
66. Vlachou S., Nomikos G.G., Stephens D.N., and Panagis G. Lack of evidence for appetitive effects of delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behavioural Pharmacology 18 4 (2007) 311-319
67. Wise R.A. Brain reward circuitry: Insights from unsensed incentives. Neuron 36 2 (2002) 229-240
68. Wise R.A. Dopamine, learning and motivation. Nature Reviews Neuroscience 5 6 (2004) 483-494
69. Zakharova E., Leoni G., Kichko I., and Izenwasser S. Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats. Behavioural Brain Research 198 1 (2009) 45-50
70. Zarrindast M.R., Nasehi M., Rostami P., Rezayof A., and Fazli-Tabaei S. Repeated administration of dopaminergic agents in the dorsal hippocampus and morphine-induced place preference. Behavioural Pharmacology 16 2 (2005) 85-92
71. Zimmer A., Valjent E., Konig M., Zimmer A.M., Robledo P., Hahn H., Valverde O., and Maldonado R. Absence of delta-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. Journal of Neuroscience 21 23 (2001) 9499-9505